	Sialylation-Siglec glyco-immune checkpoints in hepatocellular carcinoma: mechanisms of immune evasion, therapeutic resistance, and postoperative recurrence. Front Immunol Zhang K, Zhang L, Long N, Zhao H, Lu X, Xu Y. PMID: 43017000 [PubMed - indexed for MEDLINE]
	Combating Sorafenib Resistance in Hepatocellular Carcinoma: Unlocking Potential with Combination Therapies and Structure-Activity Relationship Studies. Anticancer Agents Med Chem Sharma N, Bhati A, Shah K, Dewangan HK. PMID: 43015971 [PubMed - indexed for MEDLINE]
	Changing etiological spectrum and the rise of metabolic risk in liver cancer burden in China (1990-2021) with projections to 2036: a decomposition analysis based on the GBD 2021 study. BMC Cancer Hao Y, Liu Z, Jiang Y, Zhang S, Wang X, Gao H, Zhu H, Zhou X, Lu J, Niu Z, Yang F. PMID: 43015651 [PubMed - indexed for MEDLINE]
	Association between alpha-fetoprotein elevation and recurrence in patients who achieved normalized alpha-fetoprotein after curative resection for hepatocellular carcinoma: A retrospective cohort study. Medicine (Baltimore) Hwang JA, Lee J, Yi KS, Choi CH, Park KS, Min JH. PMID: 43012784 [PubMed - indexed for MEDLINE]
	Harnessing the Immune System in Hepatocellular Carcinoma Targeting: Mechanistic Insights and Therapeutic Potential of Natural Products and Traditional Chinese Medicine. Drug Des Devel Ther Hao L, Li L, Chen Y, Gao J, Xie Y, Li Q, Lu J, Zhang Z. PMID: 43011505 [PubMed - indexed for MEDLINE]
	Decoupled Signal Transduction via a Non-Copper Laccase Mimic for CRISPR-Based Electrochemical Detection of Hepatocellular Carcinoma. Anal Chem Li H, Zhou Y, Yan Y, Ye J, Dong X, Chen M, Meng T, Jiao D, Wang D, Zhu L, Yang X. PMID: 43010442 [PubMed - indexed for MEDLINE]
	Double-Lock Superpolymer TDN is Used for the Theranostics of HCC. Anal Chem Dou C, Liao C, Liu J, Xie X, Tang M, Cao C. PMID: 43010402 [PubMed - indexed for MEDLINE]
	Ceramide-mediated immunometabolic modulation in hepatocellular carcinoma (HCC): emerging functions of sphingomyelin phosphodiesterase 3 (SMPD3). Mol Biol Rep Mohammadi S, Darweesh M, Al-Roshdi M, Rahmati M, Al-Hamadani M, Al-Musharfi M, Al-Harrasi A. PMID: 43007472 [PubMed - indexed for MEDLINE]
	Construction of a UBE2S- and Ferroptosis-Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S-Mediated Ferroptosis. Hum Mutat Zhang H, Yao J, Cao J, Guo Z, Jiang W, Li K, Wang X, Mo Z. PMID: 43005526 [PubMed - indexed for MEDLINE]
	HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade. Front Immunol Wei Z, Liao Y. PMID: 43005461 [PubMed - indexed for MEDLINE]
	Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study. Front Immunol Wang Z, Wu B, Wu C, Wu H, Zhao S, Ye S, Li X, Zhan P, Li X, Li Z. PMID: 43005167 [PubMed - indexed for MEDLINE]
	Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response of Hepatocellular Carcinoma: Single-Center Development and Korea-Nationwide Multi-Center Validation Studies. Ann Transplant Kang WH, Hwang S, Ahn CS, Moon DB, Song GW, Jung DH, Park GC, Yoon YI, Lee KW, Kim JM, Joo DJ, You YK, Ryu JH, Han YS, Jeong J. PMID: 43004659 [PubMed - indexed for MEDLINE]
	Subtype conversion and metastatic timing in breast cancer liver metastasis. World J Surg Oncol Xue Y, Ou Z, Li A, Huo D, Wang J. PMID: 43004338 [PubMed - indexed for MEDLINE]
	Integrated interpretability machine learning and clinlabomics analysis for the risk prediction of hepatocellular carcinoma. BMC Cancer Yang WX, Wang YY, Ye Z, Dang YQ, Wang FF, Gao LN, Zhao DD, He JH, You CG. PMID: 43004308 [PubMed - indexed for MEDLINE]
	Exercise-containing multimodal prehabilitation on functional outcome of patients with hepatobiliary and pancreatic cancer after surgery: a meta-analysis. BMC Cancer She Z, Jiang Q, Lu W. PMID: 43004285 [PubMed - indexed for MEDLINE]
	Cancer Immunotherapy for Hepatocellular Carcinoma: Current Drug Strategies, Resistance, Biomarkers, and Future Directions. Drug Des Devel Ther Zhong SS, Yu Y, Zhong XH, Xie J, Liu MS. PMID: 43001154 [PubMed - indexed for MEDLINE]
	Combined neutrophil-to-lymphocyte ratio and albumin-bilirubin grade predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. BMC Gastroenterol Hong YM. PMID: 43000240 [PubMed - indexed for MEDLINE]
	Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors. Cancer Med Deng X, Wu D, Ni L, Li W, Liu Z, Liu J, Liu J. PMID: 42998017 [PubMed - indexed for MEDLINE]
	Preoperative classification of histopathological growth patterns in colorectal liver metastases using prospective 18Â F-FDG PET/CT. Clin Exp Metastasis Jonsson J, Ling A, Axelsson J, Lundin M, Vermeulen P, Riklund K, Nyström H. PMID: 42995314 [PubMed - indexed for MEDLINE]
	Primary splenic angiosarcoma initially diagnosed as littoral cell angioma: A case report of a diagnostic pitfall. Medicine (Baltimore) Yu Y, Zhang H, Zhang G, Xu L. PMID: 42994881 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 78089

Page 1 of 3905



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy